Hacker News Reader

If you are curious, this is the actual Chinese trial registration (edit: not results) about hydroxichloroquine (among the many citations in the pdf)

http://www.chictr.org.cn/showprojen.aspx?proj=48880

View on HN

Just to make this clear: This is a trial registration, not a result.

Is this an ongoing trial? When are the results due? 3x100 subjects (is that correctly read?) seems quite powerful.

Yes it seems they have 100 on one dosage, 100 one a different dosage and 100 in a placebo group.

According to the register, the study execution time should be "2020-01-31 To 2020-02-29"

But nobody seems to have any insight on the final results. But I would recommend this article with comments of the study leader (Dr Zhang Zhan). The article also explains how they initially discovered the efficiency of the drug by just noticing there were no lupus patients (who were under chronic treatment of hydroxichloroquine) infected with covid19.

https://www.jqknews.com/news/388543-The_novel_coronavirus_pn...

And apparently those Lupus patients are now having trouble getting their prescriptions filled.

> But nobody seems to have any insight on the final results.

I assume that means it's either too small of a sample size or it doesn't make enough of an affect?

A study designed like this shouldn’t have data analysis before it is all collected.

Reply on news.ycombinator.com